Diabetes Medication
Newjenta CR Tab. from Korea United Pharm Inc. is a combination diabetes medication designed to enhance patient convenience. This tablet combines 5 mg of Linagliptin and 1000 mg of Metformin Hydrochloride, offering an effective solution for blood glucose management.
Linagliptin, a DPP-4 inhibitor, is known for its cardiovascular and renal safety, effectively controlling blood sugar by inhibiting glucose production in the liver. The extended-release formulation of Newjenta CR Tab. allows for once-daily dosing, providing long-lasting blood sugar control. Additionally, the reduced size of the Metformin extended-release layer improves the ease of ingestion, making it a convenient option for patients.
The Dapa-U Tab. is another advanced diabetes treatment from Korea United Pharm Inc., featuring Dapagliflozin Propanediol Hydrate as its active ingredient. This medication functions as an SGLT-2 inhibitor, preventing glucose reabsorption in the kidneys and promoting glucose excretion through urine, effectively lowering blood sugar levels.
Beyond glycemic control, Dapa-U Tab. offers benefits such as weight reduction, cardiovascular protection, and kidney protection. It can be used as a monotherapy or in combination with other diabetes treatments like Metformin. With its once-daily dosing, Dapa-U Tab. ensures continuous blood sugar management, enhancing patient adherence and convenience.
Founded in 1987, Korea United Pharm Inc. is a leading pharmaceutical company specializing in therapeutic drugs, with a strong focus on research and development. The company has established subsidiaries in key markets such as Vietnam, the Philippines, Thailand, and Indonesia, fulfilling its vision of becoming a multinational pharmaceutical company led by Koreans. With over 10% of its annual sales invested in R&D, Korea United Pharm is recognized as a top-tier research-driven pharmaceutical company in Korea, particularly in the development of Incrementally Modified Drugs (IMDs).
The company’s technological expertise and product excellence have been acknowledged both domestically and internationally, with accolades including the designation of its modified drugs, Cilostan CR (antithrombotic) and Clanza CR (anti-inflammatory analgesic), as “Next-Generation World-Class Products” by the Ministry of Trade, Industry, and Energy.
Korean-Products.com | Blog Magazine of Korean products, brands and Goods
